BRIEF published on 09/05/2025 at 15:05, 1 year 1 month ago Onco-Innovations nomme le Dr John Mackey au conseil consultatif Essais Cliniques John Mackey Oncologie Onco-Innovations Inhibiteur De PNKP
PRESS RELEASE published on 09/05/2025 at 15:00, 1 year 1 month ago Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board Onco-Innovations appoints Dr. John Mackey, expert in oncology and clinical trials, to Scientific & Clinical Advisory Board, enhancing translational research capabilities for PNKP inhibitor program Clinical Trials Oncology Onco-Innovations PNKP Inhibitor Dr. John Mackey
BRIEF published on 08/15/2025 at 15:20, 1 year 1 month ago Onco-Innovations Achieves High Warrant Exercise Rate Warrants Non-dilutive Financing Cancer Research Shareholder Confidence Capital Strategy
BRIEF published on 08/15/2025 at 15:20, 1 year 1 month ago Onco-Innovations atteint un taux d'exercice de mandat élevé Financement Non Dilutif Confiance Des Actionnaires Mandats Stratégie De Capital Recherche Sur Le Cancer
PRESS RELEASE published on 08/15/2025 at 15:15, 1 year 1 month ago Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised Onco-Innovations announces successful execution of key capital strategy with over 90% of outstanding warrants exercised at $0.60, reinforcing investor confidence and internal financing effectiveness Warrants Investor Confidence Capital Strategy Onco-Innovations Internal Financing
BRIEF published on 08/13/2025 at 23:05, 1 year 1 month ago Onco-Innovations Closes $400,000 Private Placement Private Placement Securities Regulation Shares And Warrants Onco-Innovations Funding And Development
BRIEF published on 08/13/2025 at 23:05, 1 year 1 month ago Onco-Innovations clôture un placement privé de 400 000 $ Placement Privé Réglementation Des Valeurs Mobilières Actions Et Bons De Souscription Onco-Innovations Financement Et Développement
PRESS RELEASE published on 08/13/2025 at 23:00, 1 year 1 month ago Onco-Innovations Announces Closing of Private Placement Onco-Innovations Limited announces the closing of a non-brokered private placement, raising $400,000 for general corporate purposes and cancer research. Statutory hold period applies. Not for distribution in the US Non-brokered Private Placement Cancer Research Statutory Hold Period Onco-Innovations Limited Not For Distribution
BRIEF published on 08/04/2025 at 22:10, 1 year 2 months ago Onco-Innovations Sets Course for Human Trials with Avance Clinical Agreement Clinical Trial Onco-Innovations PNKP Inhibitor Avance Clinical Regulatory Preparations
BRIEF published on 08/04/2025 at 22:10, 1 year 2 months ago Onco-Innovations ouvre la voie aux essais cliniques sur l'homme grâce à un accord clinique avancé Essai Clinique Onco-Innovations Inhibiteur De PNKP Avance Clinique Préparations Réglementaires
Published on 10/05/2026 at 22:30, 4 hours 18 minutes ago EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 12 hours 3 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 12 hours 18 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 12 hours 18 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 12 hours 48 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 22:25, 4 hours 23 minutes ago LumApps Named a Leader in 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions
Published on 10/05/2026 at 22:05, 4 hours 43 minutes ago AMPERA SUBMITS COMPREHENSIVE ENGAGEMENT PLAN TO THE U.S. NUCLEAR REGULATORY COMMISSION
Published on 10/05/2026 at 21:10, 5 hours 38 minutes ago Shelly Group Board of Directors considers EUR 70.00 offer price fair and supports Schneider Electric’s voluntary public tender offer
Published on 10/05/2026 at 21:05, 5 hours 43 minutes ago EQS-Adhoc: Shelly Group SE: Board of Directors with positive opinion on the registered voluntary public tender offer by Schneider Electric SE
Published on 10/05/2026 at 20:15, 6 hours 33 minutes ago EQS-Adhoc: United Internet AG participates in capital increase against contributions in kind at 1&1 AG
Published on 10/05/2026 at 22:12, 4 hours 36 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 4 hours 36 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 8 hours 35 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 8 hours 35 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 8 hours 48 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
